KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA)

Historical Holders from Q3 2022 to Q3 2025

Symbol
KALA on Nasdaq
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
9,818,182
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
1,734,395
Holdings value
$2,653,735
% of all portfolios
0%
Number of holders
21
Number of buys
13
Number of sells
-13
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
OXFORD FINANCE LLC 16.5% $1,215,000 1,620,000 OXFORD FINANCE LLC 25 Nov 2025
BAKER BROS. ADVISORS LP 9.99% 0% $11,372,470 744,759 0% Baker Bros. Advisors LP 02 Oct 2025
SR ONE CAPITAL MANAGEMENT, LLC 4.6% -15% $5,255,568 -$1,020,402 344,176 -16.3% SR One Capital Management, LLC 14 Oct 2025
ADAR1 Capital Management, LLC 4.91% $1,270,559 298,955 ADAR1 Capital Management, LLC 31 Dec 2024
Point72 Asset Management, L.P. 0% -95.7% $393 -$717,340 257 -99.9% Point72 Asset Management, L.P. 30 Sep 2025

Institutional Holders of KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1,734,395 $2,653,735 -$8,492,399 $1.53 21
2025 Q2 3,640,815 $17,329,892 -$2,659,836 $4.76 28
2025 Q1 4,140,775 $23,727,155 +$3,688,829 $5.73 26
2024 Q4 3,460,017 $24,012,460 +$9,345,854 $6.94 29
2024 Q3 2,117,088 $12,067,800 +$82,464 $5.7 26
2024 Q2 2,091,840 $14,831,107 +$10,436,290 $7.09 27
2024 Q1 616,773 $4,884,504 +$713,767 $7.97 27
2023 Q4 525,810 $3,681,120 +$62,131 $7 23
2023 Q3 513,683 $4,572,074 +$1,116,796 $8.9 24
2023 Q2 380,984 $5,558,799 +$892,555 $14.59 26
2023 Q1 319,440 $4,808,013 -$2,074,855 $15.05 22
2022 Q4 324,124 $12,362,867 +$12,342,867 $38.15 27
2022 Q3 90,500 $20,000 +$20,000 $0.221 1